Please login to the form below

Not currently logged in
Email:
Password:

ADA 2013

This page shows the latest ADA 2013 news and features for those working in and with pharma, biotech and healthcare.

ADA: Boehringer/ Lilly's empagliflozin shows blood glucose benefits

ADA: Boehringer/ Lilly's empagliflozin shows blood glucose benefits

ADA: Boehringer/ Lilly's empagliflozin shows blood glucose benefits. Phase III results for diabetes candidate also indicate significant weight loss. ... When taken together, the trials, which were presented over the weekend at the American Diabetes

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics